Research graph
References from Comparative Analysis of In Vitro Permeation and Human Pharmacokinetic Data for a Bioadhesive Vaginal Tablet as a Potential Clinical Approach for Bacterial Vaginosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Exploring the potential of vaginal drug delivery: Innovations, efficacy, and therapeutic prospects
10.1093/jpp/rgaf045 · 2025 · External reference
10.3390/polym13010026
10.3390/polym13010026 · External reference
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring
10.1080/10717544.2023.2180113 · 2023 · External reference
Exploring the Safety and Compatibility of a Ready-to-Use Vaginal Film Vehicle for Drug Delivery: A Clinical Assessment
10.4236/arsci.2025.133009 · 2025 · External reference
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: A soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy
10.1080/13697137.2023.2211763 · 2023 · External reference
Pharmacokinetics of vaginal versus buccal misoprostol for labor induction at term
10.1111/cts.13306 · 2022 · External reference
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis
10.1093/jac/dkac386 · 2023 · External reference
Studies and methodologies on vaginal drug permeation
10.1016/j.addr.2015.02.003 · 2015 · External reference
10.3390/ph18020195
10.3390/ph18020195 · External reference
In vitro permeation testing for the evaluation of drug delivery to the skin
10.1016/j.ejps.2024.106873 · 2024 · External reference
Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w)
10.1016/j.yrtph.2016.11.008 · 2016 · External reference
Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion
10.1016/j.ijpharm.2023.123269 · 2023 · External reference
Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate—The effect of vaginal pH on drug carrier performance
10.1016/j.ijbiomac.2022.09.207 · 2022 · External reference
Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers—Antiherpes activity and penetration behavior across the human vaginal epithelium
10.1080/10717544.2021.1992037 · 2021 · External reference
A vaginal fluid simulant
10.1016/s0010-7824(99)00010-4 · 1999 · External reference
Unresolved reference
External reference
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
10.1089/aid.2005.21.845 · 2005 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge
10.1177/0956462418785451 · 2018 · External reference
The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants
10.1177/09564624231179505 · 2023 · External reference
In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients
10.1016/j.antiviral.2012.09.011 · 2012 · External reference
Increased Dapivirine Tissue Accumulation through Vaginal Film Codelivery of Dapivirine and Tenofovir
10.1021/mp4007024 · 2014 · External reference
10.3390/molecules29102334
10.3390/molecules29102334 · External reference
Are Vaginal Symptoms Ever Normal? A Review of the Literature
2004 · External reference
Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet
10.1093/humrep/14.3.606 · 1999 · External reference
Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration
10.1007/bf03192299 · 1998 · External reference
Serum concentrations of estriol vary widely after application of vaginal oestriol cream
10.1111/bcp.14635 · 2021 · External reference
Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration
10.1007/bf03192299 · ExternalCitation · doi-reference
Studies and methodologies on vaginal drug permeation
10.1016/j.addr.2015.02.003 · ExternalCitation · doi-reference
In vitro profiling of the vaginal permeation potential of anti-HIV microbicides and the influence of formulation excipients
10.1016/j.antiviral.2012.09.011 · ExternalCitation · doi-reference
In vitro permeation testing for the evaluation of drug delivery to the skin
10.1016/j.ejps.2024.106873 · ExternalCitation · doi-reference
Chitosan-poly(ethylene oxide) nanofibrous mat as a vaginal platform for tenofovir disoproxyl fumarate—The effect of vaginal pH on drug carrier performance
10.1016/j.ijbiomac.2022.09.207 · ExternalCitation · doi-reference
Detailed pharmacokinetic characterization of advanced topical acyclovir formulations with IVPT and in vivo Open Flow Microperfusion
10.1016/j.ijpharm.2023.123269 · ExternalCitation · doi-reference
Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w)
10.1016/j.yrtph.2016.11.008 · ExternalCitation · doi-reference
A vaginal fluid simulant
10.1016/s0010-7824(99)00010-4 · ExternalCitation · doi-reference
Increased Dapivirine Tissue Accumulation through Vaginal Film Codelivery of Dapivirine and Tenofovir
10.1021/mp4007024 · ExternalCitation · doi-reference
Potential of mucoadhesive chitosan glutamate microparticles as microbicide carriers—Antiherpes activity and penetration behavior across the human vaginal epithelium
10.1080/10717544.2021.1992037 · ExternalCitation · doi-reference
First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring
10.1080/10717544.2023.2180113 · ExternalCitation · doi-reference
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: A soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy
10.1080/13697137.2023.2211763 · ExternalCitation · doi-reference
In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials
10.1089/aid.2005.21.845 · ExternalCitation · doi-reference
Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet
10.1093/humrep/14.3.606 · ExternalCitation · doi-reference
A Phase 1 pharmacokinetic study of a single-dose bioadhesive clindamycin 2% gel for bacterial vaginosis
10.1093/jac/dkac386 · ExternalCitation · doi-reference
Exploring the potential of vaginal drug delivery: Innovations, efficacy, and therapeutic prospects
10.1093/jpp/rgaf045 · ExternalCitation · doi-reference
Serum concentrations of estriol vary widely after application of vaginal oestriol cream
10.1111/bcp.14635 · ExternalCitation · doi-reference
Pharmacokinetics of vaginal versus buccal misoprostol for labor induction at term
10.1111/cts.13306 · ExternalCitation · doi-reference
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge
10.1177/0956462418785451 · ExternalCitation · doi-reference
The frequency and duration of side-effects associated with the use of oral metronidazole; A prospective study of VITA trial participants
10.1177/09564624231179505 · ExternalCitation · doi-reference
10.3390/molecules29102334
10.3390/molecules29102334 · ExternalCitation · doi-reference
10.3390/ph18020195
10.3390/ph18020195 · ExternalCitation · doi-reference
10.3390/polym13010026
10.3390/polym13010026 · ExternalCitation · doi-reference
Exploring the Safety and Compatibility of a Ready-to-Use Vaginal Film Vehicle for Drug Delivery: A Clinical Assessment
10.4236/arsci.2025.133009 · ExternalCitation · doi-reference
